Cargando…
Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
Background: Pancreatic cancer (PC) is a lethal malignancy with an extremely unfavorable 5-year survival rate and a high mortality rate. Glutathione S-transferase mu-3 (GSTM3) has been shown to exert different functions in the progression and development of various cancers, except for PC. This study...
Autores principales: | Wang, Shunda, Yang, Jinshou, Ding, Cheng, Li, Junjie, You, Lei, Dai, Menghua, Zhao, Yupei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485563/ https://www.ncbi.nlm.nih.gov/pubmed/32984010 http://dx.doi.org/10.3389/fonc.2020.01539 |
Ejemplares similares
-
High Expression of MUC15 Is Correlated with Poor Prognosis of Pancreatic Cancer and Promotes Migration, Invasion, and Chemo-Resistance In Vitro
por: Wang, Shunda, et al.
Publicado: (2020) -
GSTM3 Function and Polymorphism in Cancer: Emerging but Promising
por: Wang, Shunda, et al.
Publicado: (2020) -
Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy
por: Wang, Shunda, et al.
Publicado: (2020) -
Glutathione S-Transferases in Pediatric Cancer
por: Luo, Wen, et al.
Publicado: (2011) -
Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
por: Wang, Shunda, et al.
Publicado: (2021)